In a small open-label randomized trial, 2 platelet-rich plasma injections were associated with greater 6-month improvements in pain and function than corticosteroid injection or oral aceclofenac among patients awaiting knee arthroplasty.
High-revision-rate surgeons saw a late revision signal after adopting robotic-assisted total knee arthroplasty, despite no overall reduction in revision rates or failure modes.
A Geneva registry study points surgeons toward residual pain over functional limitation as the outcome that tracks patient satisfaction one year after hip or knee replacement.